Audio Interviews

ValueTheMarkets Podcast 030 – with Cathal Friel, CEO of Open Orphan (ORPH)

18 Nov 2019 | by: James Moore

Today’s guest on the ValueTheMarkets podcast is Cathal Friel, CEO of Open Orphan. (LSE:ORPH)  The company is focused on rare disease and orphan drug pharma services and aims to achieve rapid growth thorough the acquisition of smaller, high-margin pharma service providers. Open Orphan has just announced it has secured another new contract, this time with Carna Bioscience for a First In Human Clinical pharmacology trial.


The contract sees the Venn Life Sciences part of Open Orphan provide Carna with a range of expertise from chemistry manufacturing and controls to clinical trial management as well as biometry, legal and regulatory support.

In the interview, Cathal talks further about the deal and gives an update on progress of the integration of Venn Life Sciences which Open Orphan acquired via a reverse takeover earlier in the summer.

All opinions expressed are those of ValueTheMarkets and the respective guests unless otherwise stated and should not be construed as investment advice or a recommendation to buy shares in any featured Company. Listeners are advised to do their own extensive research before buying shares which, as with all small-cap exploration stocks, should be viewed as high risk. Investors should also seek the advice of a qualified investment adviser or stockbroker as they deem appropriate.

Valuethemarkets.com, Digitonic Ltd (and our owners, directors, officers, managers, employees, affiliates, agents and assigns) are not responsible for the content or accuracy of this article. The information included in this article is based solely on information provided by the company or companies mentioned above.

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.

  • Digitonic Ltd, the owner of ValueTheMarkets.com, has been paid for the production this piece by the company or companies mentioned above.

More News & Analysis

European economy grows 2%, ending double-dip recession

Europe emerged from a double-dip recession in the second quarter with stronger than expected growth of 2.0% over the quarter before, according to official figures released Friday, as southern European economies previously hard hit by the pandemic showed surprisingly strong results.

Air France-KLM reports huge Q2 loss, sees signs of recovery

French-Dutch airline group Air France-KLM said Friday that the “first signs of recovery are visible” in bookings amid easing pandemic travel restrictions as it reported a second-quarter net loss of nearly 1.5 billion euros ($1.8 billion).

Is Disney a good investment?

Disney is one of the biggest and most recognised companies in the world, and their stock has performance has been strong after the release of Disney+, but does Disney’s stock represent good value for the retail investor?